On the recordDecember 12, 2017
We must find workable solutions that incentivize competition in the pharmaceutical marketplace, reward value, and encourage the development of affordable and high quality drugs.
Source
congress.govEditor's note · Context
Walden emphasizes the need for competition and affordability in pharmaceuticals.
Share
More from Greg Walden
Sep 30, 2020
Today's hearing will examine an important topic concerning access and affordability of energy for low-income or otherwise disadvantaged households.
Dec 7, 2020
I thank all my colleagues who came down tonight to share these words. I want to assure the American people--it feels like a eulogy--I am actually still alive but deeply indebted for their generosity, their kindness, and their words…
Dec 9, 2020
I don't believe I have any other speakers on my side of the aisle on this measure. I urge its passage, and I yield back the balance of my time.
Dec 9, 2020
It is a great privilege now to recognize the gentleman from Kentucky (Mr. Guthrie), who is the top Republican on the Oversight and Investigations Subcommittee and has really done incredible work as we put together our package on Operation…
Other voices in this conversation
